NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC) Meeting Abstract


Authors: Mamounas, E. P.; Bandos, H.; White, J. R.; Julian, T. B.; Khan, A. J.; Shaitelman, S. F.; Torres, M. A.; Vicini, F. A.; Ganz, P. A.; McCloskey, S. A.; Paik, S.; Gupta, N.; Li, X. A.; DiCostanzo, D. J.; Curran, W. J. Jr; Wolmark, N.
Abstract Title: NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC)
Meeting Title: 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017)
Journal Title: Cancer Research
Volume: 78
Issue: 4 Suppl.
Meeting Dates: 2017 Dec 5-9
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000425489400079
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS17-OT2-03-02
Notes: Meeting Abstract: OT2-03-02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Atif Jalees Khan
    152 Khan
Related MSK Work